State Street Corp Bei Gene, Ltd. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Bei Gene, Ltd. stock. As of the latest transaction made, State Street Corp holds 2,226 shares of BGNE stock, worth $421,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,226
Previous 2,300 3.22%
Holding current value
$421,225
Previous $328,000 52.13%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$143.93 - $224.51 $10,650 - $16,613
-74 Reduced 3.22%
2,226 $499,000
Q2 2024

Aug 14, 2024
SELL
$129.52 - $174.32 $12,952 - $17,432
-100 Reduced 4.17%
2,300 $328,000
Q1 2024

May 15, 2024
BUY
$141.8 - $181.47 $14,180 - $18,147
100 Added 4.35%
2,400 $375,000
Q4 2023

Feb 14, 2024
SELL
$158.67 - $201.58 $32,210 - $40,920
-203 Reduced 8.11%
2,300 $414,000
Q3 2023

Nov 14, 2023
SELL
$179.87 - $225.13 $1.24 Million - $1.55 Million
-6,900 Reduced 73.38%
2,503 $450,000
Q2 2023

Aug 14, 2023
SELL
$178.3 - $266.78 $45.8 Million - $68.5 Million
-256,808 Reduced 96.47%
9,403 $1.68 Million
Q1 2023

May 15, 2023
BUY
$215.53 - $274.5 $21.5 Million - $27.4 Million
99,974 Added 60.14%
266,211 $57.4 Million
Q4 2022

Feb 14, 2023
SELL
$125.51 - $229.3 $72.2 Million - $132 Million
-575,410 Reduced 77.59%
166,237 $36.6 Million
Q3 2022

Nov 15, 2022
SELL
$131.8 - $202.24 $3.3 Million - $5.06 Million
-25,043 Reduced 3.27%
741,647 $100 Million
Q2 2022

Aug 15, 2022
SELL
$121.11 - $216.05 $8.34 Million - $14.9 Million
-68,856 Reduced 8.24%
766,690 $124 Million
Q1 2022

May 16, 2022
SELL
$146.52 - $269.56 $10.8 Million - $19.9 Million
-73,809 Reduced 8.12%
835,546 $158 Million
Q4 2021

Feb 14, 2022
BUY
$248.56 - $389.34 $1.06 Million - $1.66 Million
4,273 Added 0.47%
909,355 $246 Million
Q3 2021

Nov 15, 2021
BUY
$249.6 - $403.14 $4.64 Million - $7.5 Million
18,594 Added 2.1%
905,082 $329 Million
Q2 2021

Aug 16, 2021
BUY
$292.75 - $367.01 $17.6 Million - $22 Million
59,999 Added 7.26%
886,488 $304 Million
Q1 2021

May 17, 2021
BUY
$260.64 - $382.12 $20.8 Million - $30.5 Million
79,837 Added 10.69%
826,489 $288 Million
Q4 2020

Feb 16, 2021
SELL
$221.31 - $316.61 $24.2 Million - $34.6 Million
-109,276 Reduced 12.77%
746,652 $193 Million
Q3 2020

Nov 10, 2020
BUY
$189.18 - $286.44 $14.4 Million - $21.8 Million
76,257 Added 9.78%
855,928 $245 Million
Q2 2020

Aug 14, 2020
SELL
$123.9 - $195.41 $8.59 Million - $13.5 Million
-69,309 Reduced 8.16%
779,671 $147 Million
Q1 2020

May 11, 2020
BUY
$121.84 - $173.19 $103 Million - $147 Million
848,980 New
848,980 $105 Million

Others Institutions Holding BGNE

# of Institutions
249
Shares Held
45.3M
Call Options Held
292K
Put Options Held
119K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $19.6B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email